SCHEMBL20282240

SCHEMBL20282240

CC[C@@H](C)Cc1ccc(C(F)(F)F)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 5/20 0.41
DAO P14920 1/20 0.41
HTR2A P28223 2/20 0.40
HTR2B P41595 2/20 0.40
HTR2C P28335 1/20 0.40
MC4R P32245 2/20 0.39
SIGMAR1 Q99720 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
ADRA2C P18825 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
OPRK1 P41145 1/20 0.39
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
IDO1 P14902 1/20 0.36
S1PR1 P21453 1/20 0.35
DPP7 Q9UHL4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23841644 0.84 DAO (0.44) PDE2ADAOHTR2AHTR2BHTR2C
SCHEMBL18733705 0.82 SLC6A4 (0.39) PDE2ADAOHTR2AHTR2BHTR2C
SCHEMBL21132234 0.81 PDE2A (0.41) PDE2AHTR2AHTR2BHTR2CSIGMAR1
SCHEMBL18896392 0.81 IDO1 (0.49) PDE2AHTR2AHTR2BHTR2CSIGMAR1
SCHEMBL25916270 0.78 NR3C1 (0.49) SLC6A4
SCHEMBL12603811 0.77 DAO (0.51) PDE2ADAOMAPTRXRARXRB
SCHEMBL18294991 0.76 DAO (0.46) PDE2ADAOHTR2AHTR2BHTR2C
SCHEMBL2654304 0.75 RXRA (0.47) MC4RMAPTRXRARXRBRXRG
SCHEMBL16950937 0.74 DAO (0.53) PDE2ADAOSIGMAR1RXRARXRB
SCHEMBL13003550 0.74 ALDH1A1 (0.46) PDE2AHTR2AHTR2BHTR2CSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018109642-A1 N-ARYL PYRAZOLES AS NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-06-21 WO disclosed